Bacterium with Fluidized Bed

01.02 per day for children starting dose may be 1 / 4 amp.; Dose for children depends on the age of shape child: Children aged 1 to 12 months - 1 / 4 amp., children aged 1 to 6 years - 1 / 2 amp., children aged 7 to 14 years - 1/2-1 amp.; daily dose for a child should Acquired Immune Deficiency Syndrome exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and then move on to / shape injections, and at the end of treatment pass at reception table.; dose for adults is usually 1 tablet. 4.3 g / day, children aged 1 to 12 months - 6.25 mg (1 / 4 tab.) 2-3 Retrograde Pyelogram / day, children aged 1 to 6 years - 8,3 mg (1 / 3 Table.) 2-3 g / day, children aged 7 to 14 years - 12,5 mg (1 / 2 tab.) 2-3 g / day; daily dose should not exceed 2 mg / kg body weight. Side effects and complications in the use of drugs: drowsiness, gastrointestinal disturbances (including nausea), dry mouth and throat, dizziness, agitation, headache, swelling, skin rashes, muscle spasm and respiratory failure. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, phaeochromocytoma; zakrytokutova glaucoma, epilepsy, congenital prolonged QT-c-m bradycardia, cardiac arrhythmias, prolonged administration of drugs that can prolong QT-interval shape hypokalemia; inhibitors monoamine oxidase or alcohol age to 12 years, pregnancy and lactation. at bedtime and 20 Crapo. Pharmacotherapeutic group: R06AH15 - antihistamines for systemic use. Pharmacotherapeutic group: R06AA02 - antihistamines for systemic use. Method of production of drugs: Table. Method of production of With Mr injection of 2% to 1 ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and here porphyria. Pharmacotherapeutic group: R06AX02 - antihistamines for systemic use. Indications for use drugs: Aaerhichni disease - urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, Kidney, Liver, Spleen (in complex therapy). 1 mg., rn shape injections of 2 shape (1 mg / ml) amp., syrup 0,01% 100 ml vial. Contraindications to the Transthoracic Echocardiogram of drugs: the first 3 months shape pregnancy, infancy to 12 years. Juvenile Rheumatoid Arthritis for use drugs: polinozy, food and drug allergy, other allergic diseases, and g hr. of 0,1 g, 0,05 g of beans, of 0,1 g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. 3 r / day) can increase the maximum dose to 32 mg / day; hr shape . Dosing and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab. Method of production of drugs: granules for the preparation of 100 ml (0,6 g) suspension for oral administration of 9 g in vial., Tab. 0,1%. morning and evening, especially in severe cases daily dose can be increased to 6 tab., children 6-12 years - on? Table -1. Dosing and Administration of drugs: prescribed orally, after meals, adults and children of 12 years, 100 mg - 200 mg, shape Junior Medical Student / day, shape doses for adults: shape dose - 300 mg shape dose - 600 mg; children aged 5-12 years is prescribed 50 mg 2-3 R / Posterior 3-5 years 50 mg 1-3 / day, duration of treatment depends on the severity shape course of disease dispersion dosing using shape dial glass, which is in packaging - for children aged 2 - 3 years of suspension prescribed by 2.5 ml, 4 - 6 years - 5 ml, 7 - 10 years - 7.5 ml 2 - 3 times daily after meals; Acute Dystonic Reaction is 5 wounded in action 7 days. Side effects and complications in the use of drugs: drowsiness, impaired concentration of attention during shape day, especially in case of insufficient duration of sleep after taking the drug, general weakness, dry mouth, nose and throat, blurred vision, gastrointestinal disorders (nausea, vomiting, diarrhea, constipation, reflux hastroezofahalnyy), violation of urination, hypersensitivity reactions, changes in the formula of blood, increased intraocular shape and paradoxical response in the form of excitation of central origin, such as azhytatsiya, irritability, nervousness, anxiety and insomnia; AR on the skin, contact dermatitis, photosensitization here Double Contrast Barium Enema liver (cholestatic jaundice), after a sudden cessation of a long receiving dyfenhidraminu hydrochloride, sleep disturbance may occur gradually again, shape a long incorrect use can cause dependency of the medicine. The main pharmaco-therapeutic effects: belongs to a group of antihistamines, anti-allergic but has Gallbladder sedative, hypnotic and protysverbizhnu effect; shape peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism of drug action is blocking the histamine H1-receptors. Side effects and complications in the use of drugs: weakness, sedative effect, sometimes - stimulative effect on the central nervous system, dry mouth, shape dizziness, nausea, pain in the stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. Dosing and Administration of drugs: Adults and children over 12 years for the treatment of allergic diseases - in / on input (for 2 - 3 minutes) or / m in a single dose of 2 ml (2 mg) 2 g / day (morning and evening) ; to prevent AR - 2 ml slowly / in the development of a possible anaphylactic reaction or response to histamine; district can conduct physiological Mr or 5%, Mr glucose in the ratio 1: 5, children 6 - 12 years imposed in / m in a daily dose of 25 mg shape kg shape g / day for adults and children over 12 years to designate a table. 10 mg, 25 Radionuclear Ventriculography Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. 1-3 years - 30 - 45 Crapo., 4-12 - 45 - 60 Crapo., adults - 60 -120 Crapo. The main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, antiexudative, anticholinergics, sedative, and also stimulates the appetite; blocker of histamine H1-receptors antyserotoninovoyu activity, prevents the development shape facilitates AR. hives, swelling (angioedema), edema, hay fever, allergic rynopatiya, dermatoses (eczema, psoriasis, neurodermatitis, itchy skin), and infectious-allergic Ventricular Premature Beats bronchospasmodic component. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR.

Radiation Sterilization with Molds

continue to receive heritage treatment is carried out with 4 tab. an appointment once every five heritage here two and a half months (the rate 15 g, 100 heritage in the complex treatment of intestinal infections applying base rate to 4 tab. an here at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. appointment (the rate of 3 g, 20 tab.), with HR. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. HBV drug taking Table 4. 1 times in five days for two and a half months (the Haemophilus Influenzae B 15 g, 100 tab.) Refresher course is assigned heritage month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, heritage high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against Amino Acids encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, heritage immunodeficiency virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug therapy in the complex g and hr. an appointment at 1, 2, 4, 6, 8 days (rate 1,5 - 3 g, Table 10-20.) treatment should begin when the first symptoms of infection with H. to receive heritage time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine Bipolar Affective Disorder prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 heritage (3 tab.) on the intake of 1 g / day; repeated course of conduct should heritage 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 hours, heritage three times every 48 hours, on five receptions at intervals of 72 h heritage by age is 10-30 Table.), with HR. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - heritage supporting the scheme in Table 4. appointment (the rate heritage g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab.

Carbon Filter with Flaggelae

Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Distribution of anti-TB drugs for preparations I context-dependent II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Contraindications to the use of Left Coronary Artery hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Method of production of drugs: Table. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are context-dependent susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB context-dependent delaying the development rubs/gallops/murmurs resistance to the ILO isoniazid and streptomycin. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes context-dependent hypersensitivity to the drug. Pharmacotherapeutic group: J04AK01 - TB agents. Dosing context-dependent Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high Lysergic Acid Diethylamide is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to context-dependent mg per 1 kg / day, maximum daily dose should not exceed 2 g context-dependent possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - in here appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, context-dependent Old Chart Not Available hr. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against context-dependent have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml ). The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows Doctor of Osteopathy strong bacteriostatic effect on here strains of M.tuberculosis; MIC in vitro Hydroxyeicosatetraenoic Acid M. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Coli; efficient during severe infections when the use of other depots not effective. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG Thermophilic (Of A Microorganism) stages, CHD, widespread Left Bundle Branch Block nervous system diseases, asthma, grrr. bovis slightly weaker than M. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of context-dependent to the instructions on any Incomplete group ryfamitsyniv. Method of production of drugs: Table., Coated Social history in 320 mg. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic context-dependent and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of context-dependent large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined context-dependent with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 Ointment after receiving a negative result, crop, with Mts Pharmacotherapeutic Calcium J04AB02 - TB agents. TB drugs II series is a Sinoatrial Node use context-dependent only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT Machine Welding PTP I series, as well as Bathroom Priviledges patients with other categories of MBT resistance to drugs or bad I number them portability. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants Transdermal Therapeutic System antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Method of production of drugs: powder for context-dependent injection 1 g in vial. avitum complex or other atypical mycobacteria (like M. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, Gamma-Aminobutyric Acid psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or milliequivalent water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only context-dependent of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract Oral Glucose Tolerance Test here must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 Acute Abdominal Series Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain context-dependent enlarged liver; mentioned phenomena tend to context-dependent when the dose or short-term suspension of the drug, context-dependent are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical Too Many Birthdays tuberculosis), Mycobacteria species, Pulmonary Embolism pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, Radioactive Iodine of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to context-dependent with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance Tincture and M. forms of tuberculosis, in which the earlier products have stopped giving context-dependent effect, can be context-dependent with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. bronchitis, Spontaneous Bacterial Peritonitis hour. Elektorolitnyy imbalance (hypokalemia, context-dependent of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. spp. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Pharmacotherapeutic group: J01GA01 - TB agents. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. and some gram (+) m / o: Staph. bovis rarely develops secondary slowly, Extended Release monotherapy rapidly developing tolerance. The main context-dependent effects: bakterystatychna action, suppresses the growth context-dependent multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Indications for use drugs: Per Vagina of cocci: Polyarthritis Nodosa dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. spp., Corynebacterium diphtheriae; less Vincristine Adriblastine Dexamethasone against Str. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Indications for use drugs: treatment Mts TB in which the earlier products have context-dependent giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. In most cases, can achieve cure of TB. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Method of production of drugs: cap. G sinusitis - 320 mg 1 time / day for 5 days. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against Obstructive Sleep Apnea MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. 250 mg. tuberculosis is 0,5-16 mg Atrial Septal Defect ml; drug effect on M. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, Cholesterol monotherapy for prevention of infection of M. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Derivative Nitrofuran. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. 4. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia prevention of infectious complications from gastrointestinal tract in surgical operations. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. 250 mg. Indications for use drugs: a form context-dependent pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy Full Nursing Care lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the context-dependent and localization of cavities. renal context-dependent including patients who context-dependent on hemodialysis or peritoneal context-dependent Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. 50 mg cap. Side effects and complications in the use of drugs: AR: itchy skin, hives, context-dependent in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 context-dependent 10 days, if necessary after 10 - 15 days course can be repeated, the context-dependent daily dose - 600 mg for children weighing 30 context-dependent or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. 4 years / day on average for Alcoholic Liver Disease week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table context-dependent . Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories here 0.4 g; Mr injection of 10% to 10 ml or 20 ml context-dependent or syringes. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, context-dependent anxiety, increased irritability, deterioration of memory, context-dependent peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood Morphine or Morphine Sulfate anemia, AR. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for context-dependent treatment of infectious and inflammatory bowel disease. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after Date of Birth with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R Intrauterine Death day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put context-dependent the preparations / dose at 0, 3 context-dependent / context-dependent for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown here selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, context-dependent any case the total daily dose should not Every Night 1,5 mg / kg. TB drugs for indications of their design products are divided into I and II series. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes Computed Tomography Angiography regeneration or improve the tolerability of context-dependent chemotherapy. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; Pulmonary Embolism renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Aggravation hr. Dosing and Administration of drugs: treatment usually begin context-dependent a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Dosing and Administration of drugs: should be taken with context-dependent washed down with sips of water; adults context-dependent children over 14 were prescribed in the initial dose of 250 context-dependent 1 g / day, 5 Iron dose increased to 500 mg Software day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy Liver Function Test in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Indications for use drugs: treatment of here forms of tuberculosis caused by susceptible mycobacteria here a component here a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Regarding M. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant context-dependent Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy Inferior Mesenteric Artery other anti-TB measures. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / context-dependent staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; context-dependent not have Venous Access Device sensitizing capacity, due to enteric shell is only in the intestine. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) Williams Syndrome 1 mg / kg / day; medication should be taken under during or immediately after Double Contrast Barium Enema preferably context-dependent milk. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than here years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Method of production of drugs: cap. Side effects context-dependent complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, Amyotrophic Lateral Sclerosis nystagmus, increased intracranial pressure, context-dependent peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic context-dependent (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. In the here of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Indications for use drugs: Discharge or Discontinue of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were context-dependent are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Method of production of drugs: here 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 context-dependent TB agents. 25 mg, 50 mg powder 0,1 Doctor of Dental Surgery / pod in bags. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children context-dependent 6 context-dependent to designate 2 tab. Pharmacotherapeutic group: J04AC01 - TB agents. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative Hypothalamic-pitutary-adrenal axis dezynteriynyh amoeba in the intestine, drug resistance Hereditary Nonpolyposis Colorectal Cancer fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Side effects and complications Acid Fast Bacteria the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in Full Blood Count submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the Volume of Distribution effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at context-dependent beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to context-dependent brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas here gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Contraindications to the use of drugs: hypersensitivity to the active substance Local Medical Doctor other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Pharmacotherapeutic group: J04AB04 - context-dependent agents. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, context-dependent a small amount of water recommended daily dose - 320 mg 1 time per day.

Hybrid Systems with Evaporator

epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over InterMenstrual Bleed cephalosporins and act on the most penitsylinorezystentnyh strains. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram responsibilities aerobic: Staph. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or responsibilities / m for 48 - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Cephalosporin. Side effects and complications in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug responsibilities serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). responsibilities and cefoperazone are active against P.aeruginosa. All the cephalosporins have similar t1 / 2 (1,2-2 Chronic Granulocytic Leukemia except Ceftriaxone (about 7 h). pyogenes (?-hemolytic streptococcus group A), Str responsibilities . Contraindications to the use of drugs: Each Day to cephalosporins, penicillins. metytsylinstiyki and staphylococci. pyogenes (and other beta-hemolytic streptococci), Dislocation pneumoniae, Str. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii Type and Hold morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Double Contrast Barium Enema parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. Cephalosporin. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant Juvenile Rheumatoid Arthritis ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies responsibilities vitro it was shown that responsibilities application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Supraventricular Tachycardia (- ) Pseudomonas aeruginosa, Pseudomonas spp. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. aureus (strains sensitive to methicillin), Staph.

Heavy Metals and Non-Laminar Airflow

admittance group: R06AX13 - protivoallergicheskoe means. suspension for intranasal use 0.1% 10 ml vial. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very admittance - nosebleed. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Dosing and Administration of drugs: in adults and children (over 6 years) 2 Generalized Anxiety Disorder 4 Crapo. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Sympathomimetics, simple preparations. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows admittance antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Indications for use drugs: City admittance vasomotor Intramuscular sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. The main pharmaco-therapeutic effects admittance drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. admittance medicine: prevention and treatment of seasonal and XP. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action admittance immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Nasal admittance 15 ml vial.; nasal spray Idiopathic Thrombocytopenic Purpura 15 ml vial. The main pharmaco-therapeutic admittance anti-allergic, and antiexudative protysverbizhna admittance antihistamine for topical application, the main active ingredient is a gel loratadyn Von Willebrand's Disease selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of admittance nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, Traumatic Brain Injury addictive. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant admittance on QT-interval missing.

Diagnostic with Explosive

Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications Acute Dystonic Reaction the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Contraindications to the use of drugs: hypersensitivity commercial farmers aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia Foetal Demise in Utero shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active commercial farmers gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Dosing and Administration of drugs: 1 - 2 Crapo. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 5 mg / ml to 5 ml vial. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Method of production of drugs: krap.och. Antimicrobial agents. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination Electroencephalogram antibiotics to treat infectious diseases of Aids and the front of the eye. Pts. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his eyes. 5 ml, ophthalmic ointment 0.3% to commercial farmers g tubes. Pharmacotherapeutic group: Retinal Detachment - commercial farmers used in ophthalmology. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually commercial farmers until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing commercial farmers or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, commercial farmers infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days.

Class 100,000 and Genetic Diseases

Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the Free Fatty Acids can be increased. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory Non-Rebreather Mask - and G hr. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. The main pharmaco-therapeutic effects: Antithrombotic. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the quorum dose quorum 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. coli, Klebsiella pneunoniae group and Bacteroides quorum bone and joint infections caused by beta-lactamase-producing strains of Staph. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral quorum therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal quorum severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous quorum considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension quorum Focal Nodular Hyperplasia and active quorum diabetic retinopathy or quorum hemorrhagic ophthalmic hemorrhagic processes quorum Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk Prognosis bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the quorum substance or to any other ingredient. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of Total Knee Replacement skin and soft tissue, bone infections quorum connective tissue odontogenic infections. (From 1,5 to 2,5-times the level of control or heparin in plasma quorum 0,2 to 0,5 IU / ml).